Passage Bio, Inc.
PASG
$0.3905
$0.012.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.06% | 34.20% | -20.94% | 4.31% | 0.28% |
| Total Depreciation and Amortization | -72.04% | -5.27% | -4.77% | -1.12% | -0.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.21% | 57.74% | 235.89% | 49.35% | 59.42% |
| Change in Net Operating Assets | 59.12% | -203.47% | 1,481.12% | 108.12% | 2.61% |
| Cash from Operations | -63.99% | -13.39% | 43.31% | 30.60% | 3.01% |
| Capital Expenditure | -- | 30.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 185.17% | -8.65% | 1,330.25% | -95.85% | 231.68% |
| Cash from Investing | 189.74% | -8.62% | 1,328.34% | -95.85% | 232.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -99.03% | 18,904.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -99.03% | 18,904.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 388.24% | -29.79% | 162.67% | -179.68% | 226.91% |